Assoc Prof Mark Chan
Meet Associate Professor Mark Chan, a senior interventional cardiologist and researcher leading major clinical trials in heart disease treatment at the National University of Singapore.
Associate Professor Mark Chan
Dr Mark Chan, MBBS, PhD, is an Associate Professor with tenure at the Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and Senior Consultant and practising interventional cardiologist at National University Heart Centre, Singapore.
In 2019, he received the National Medical Research Council Clinician Scientist Senior Investigator Award. He is deputy director of the Cardiovascular Disease Translational Research Programme, NUS, and supervises translational research and clinical trials of acute myocardial infarction at the Cardiovascular Research Institute, NUS. He leads both basic science and clinical research team at the Cardiovascular Research Institute and National University Heart Centre, Singapore.
Among other federally-funded and industry-supported projects, A/Prof Chan is the overall PI of the national Acute Myocardial Infarction: allied Health-Oriented, Patient-centred and technology-Enabled (AMI-HOPE) programme with National University Health System, Singhealth and National Healthcare Group colleagues. He is also the overall PI of the three-country randomised controlled trial of an anti-inflammatory small-molecule inhibitor to treat atherosclerosis in patients with AMI (PASSIvation of Vulnerable plaques with AZD5718 in acuTE coronary syndrome – the PASSIVATE trial).
A/Prof Chan has published more than 260 peer-reviewed papers and has published in JAMA, Circulation, JAMA Cardiology, European Heart Journal, Nature Communications, JACC Cardiovascular Interventions, Journal of Thrombosis and Haemostasis and JACC Cardiovascular Interventions.